Showing results (371-380 of 1,983) with videos related to

Sort By:
Pageof 199
The Lancet. Neurology|November 27, 2020
Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache: a multicentre, double-blind, randomised controlled trialMark Obermann, Steffen Nägel, Claudia Ose, et al.
The Lancet. Neurology|February 18, 2018
Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind studyClive Ballard, Carol Banister, Zunera Khan, et al.
The Lancet. Neurology|February 18, 2018
Diagnostic challenges in epilepsy: seizure under-reporting and seizure detectionChristian E Elger, Christian Hoppe
The Lancet. Neurology|November 4, 2017
24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trialHilkka Soininen, Alina Solomon, Pieter Jelle Visser, et al.
The Lancet. Neurology|September 19, 2020
Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenuesRalph H B Benedict, Maria Pia Amato, John DeLuca, et al.
The Lancet. Neurology|October 28, 2021
Neuromodulation in epilepsy: state-of-the-art approved therapiesPhilippe Ryvlin, Sylvain Rheims, Lawrence J Hirsch, et al.
The Lancet. Neurology|July 19, 2022
Emerging therapies for Duchenne muscular dystrophyTheodora Markati, Maryam Oskoui, Michelle A Farrar, et al.
The Lancet. Neurology|February 14, 2016
Harnessing the integrated stress response for the treatment of multiple sclerosisSharon W Way, Brian Popko
The Lancet. Neurology|September 30, 2015
A roadmap for precision medicine in the epilepsies
The Lancet. Neurology|August 25, 2015
Dementia in western Europe: epidemiological evidence and implications for policy makingYu-Tzu Wu, Laura Fratiglioni, Fiona E Matthews, et al.
Pageof 199